Duquesne University - Pain Nanomedicine

The Naval Medical Research Center intends to award a sole source contract to Duquesne University, Pittsburgh, PA, 15219. This is not a request for competitive proposals; however, if interested, the government shall consider all responses. Approval of a contract on a sole source basis is proposed to Duquesne University (DU) to provide custom design celecoxib nanoemulsion, training on how to dose and administer the custom design celecoxib-loaded nanoemulsion, and Macrophage targeted pain nanomedicine for purpose of imaging and treatment. This will support NAMRU-SA research projects with marginal disruption. POP: FY 21 - FY 22; One Base year. Please see the attached Performance Work Statement for additional details.